REG - Kosmos Energy Ltd - Director/PDMR Shareholding

Kosmos EnergyAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260313:nRSM4886Wa&default-theme=true

RNS Number : 4886W  Kosmos Energy Limited  13 March 2026

Kosmos Energy Ltd (the "Company")

PDMR Shareholding

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES

12 March 2026

The following Persons Discharging Managerial Responsibilities ("PDMRs") have
had changes in their shareholdings of Common Stock in the Company:

 PDMR                 Date of transaction  No. of shares acquired
 Andrew G. Inglis     10 March 2026        315,790
 Neal D. Shah         10 March 2026        157,894
 J. Michael Stice     10 March 2026        52,631
 Adebayo O. Ogunlesi  10 March 2026        3,157,895

 

The Notification of Dealing Form for each PDMR, which provides full details of
the transactions outlined above, can be found below.

This notification is made in accordance with Article 19 of the EU Market Abuse
Regulation.

 

Josh R. Marion

Corporate Secretary

CONTACT:

Investor Relations

Jamie Buckland
+44 203 954 2831
jbuckland@kosmosenergy.com

Media Relations

Thomas Golembeski
+1-214-445-9674
tgolembeski@kosmosenergy.com

 

 1.  Details of PDMR / person closely associated with them ("PCA")
 a)  Name                                     Andrew G. Inglis
 b)  Position / status                        Chairman and CEO
 c)  Initial notification / amendment         Initial notification
 2.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument  Common Stock, par value $0.01 per share
 b)  Nature of the transactions               315,790 shares purchased in an Underwritten Public Offering.

 c)  Currency                                 USD
     Price                                    1.90
     Volume                                   315,790
     Total                                    600,001.00
 d)  Aggregated information
     Price                                    1.90
     Volume                                   315,790
     Total                                    600,001.00
 e)  Date of the transactions                 10 March 2026
 f)  Place of the transaction                 NYSE

 

 1.  Details of PDMR / person closely associated with them ("PCA")
 a)  Name                                     Neal D. Shah
 b)  Position / status                        Senior Vice President and CFO
 c)  Initial notification / amendment         Initial notification
 2.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument  Common Stock, par value $0.01 per share
 b)  Nature of the transactions               157,894 shares purchased in an Underwritten Public Offering.

 c)  Currency                                 USD
     Price                                    1.90
     Volume                                   157,894
     Total                                    299,998.60
 d)  Aggregated information
     Price                                    1.90
     Volume                                   157,894
     Total                                    299,998.60
 e)  Date of the transactions                 10 March 2026
 f)  Place of the transaction                 NYSE

 

 1.  Details of PDMR / person closely associated with them ("PCA")
 a)  Name                                     J. Michael Stice
 b)  Position / status                        Director
 c)  Initial notification / amendment         Initial notification
 2.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument  Common Stock, par value $0.01 per share
 b)  Nature of the transactions               52,631 shares purchased in an Underwritten Public Offering.

 c)  Currency                                 USD
     Price                                    1.90
     Volume                                   52,631
     Total                                    99,998.90
 d)  Aggregated information
     Price                                    1.90
     Volume                                   52,631
     Total                                    99,998.90
 e)  Date of the transactions                 10 March 2026
 f)  Place of the transaction                 NYSE

 

 1.  Details of PDMR / person closely associated with them ("PCA")
 a)  Name                                     Adebayo O. Ogunlesi
 b)  Position / status                        Director
 c)  Initial notification / amendment         Initial notification
 2.  Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument  Common Stock, par value $0.01 per share
 b)  Nature of the transactions               3,157,895 shares purchased in an Underwritten Public Offering.

 c)  Currency                                 USD
     Price                                    1.90
     Volume                                   3,157,895
     Total                                    6,000,000.50
 d)  Aggregated information
     Price                                    1.90
     Volume                                   3,157,895
     Total                                    6,000,000.50
 e)  Date of the transactions                 10 March 2026
 f)  Place of the transaction                 NYSE

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHSFEFUEEMSEED



            Copyright 2019 Regulatory News Service, all rights reserved